Search Results - "Holkar, Neelam"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Dual effects of NV-CoV-2 biomimetic polymer: An antiviral regimen against COVID-19 by Chakraborty, Ashok, Diwan, Anil, Chiniga, Vijetha, Arora, Vinod, Holkar, Preetam, Thakur, Yogesh, Tatake, Jay, Barton, Randall, Holkar, Neelam, Pandey, Rajesh, Pond, Bethany

    Published in PloS one (30-12-2022)
    “…Remdesivir (RDV) is the only antiviral drug approved for COVID-19 therapy by the FDA. Another drug LAGEVRIO™ (molnupiravir) though has not been approved yet by…”
    Get full text
    Journal Article
  2. 2

    Mechanism of Antiviral Activities of Nanoviricide's Platform Technology based Biopolymer (NV-CoV-2) by Chakraborty, Ashok, Diwan, Anil, Arora, Vinod, Thakur, Yogesh, Chiniga, Vijetha, Tatake, Jay, Pandey, Rajesh, Holkar, Preetam, Holkar, Neelam, Pond, Bethany

    Published in AIMS public health (01-01-2022)
    “…NV-CoV-2 is a nanoviricide that is covalently bonded with polyethylene glycol (PEG) and alkyl pendants. This molecular design is used to attack many strains of…”
    Get full text
    Journal Article
  3. 3

    A New Antiviral Regimen Against SARS-CoV-2 Based on Nanoviricide’s Biopolymer (NV-CoV-2) by Chakraborty, Ashok, Diwan, Anil, Barton, Randall, Arora, Vinod, Thakur, Yogesh, Chiniga, Vijetha, Tatake, Jay, Pandey, Rajesh, Holkar, Preetam, Holkar, Neelam, Pond, Bethany

    Published in Frontiers in nanotechnology (13-07-2022)
    “…NV-CoV-2, a nanoviricide composed of covalently attached polyethylene glycol and alkyl pendants that are designed to bind free virion particles of multiple…”
    Get full text
    Journal Article